Clinical Trial Update: A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 long-term treatment extension study of niraparib for participants who completed a prior GSK/TESARO Niraparib tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Zejula (niraparib) (niraparib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Ovarian Neoplasms, Breast Neoplasms | Phase 2 | Status: RECRUITING